He earned his MD-PhD from the University of Pennsylvania School of Medicine’s Combined Degree Program and continued his clinical training at Penn, completing an internal medicine residency and Hematology/Oncology fellowship. Dr. Park’s research interests include identifying the genetic mediators of breast carcinogenesis and drug resistance. He continues to serve as an attending physician in the solid tumor oncology service and has a strong interest in house staff and medical/graduate student education.